Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GYRE THERAPEUTICS, INC. | Director | Common Stock | 1.64K | $19.6K | $12.00 | Jun 28, 2024 | Direct |
GYRE THERAPEUTICS, INC. | Director | Common Stock | 563 | $6.76K | $12.00 | Jun 28, 2024 | By The Usman Family Trust |
GYRE THERAPEUTICS, INC. | Director | Common Stock | 77 | $924 | $12.00 | Jun 28, 2024 | By Nassim Usman IRA |
GYRE THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 278K | Jun 28, 2024 | Direct | ||
CATALYST BIOSCIENCES, INC. | Director | Series Y Preferred Stock | 0 | Aug 31, 2023 | By Nassim Usman IRA | ||
CATALYST BIOSCIENCES, INC. | Director | Series Y Preferred Stock | 0 | Aug 31, 2023 | By The Usman Family Trust | ||
CATALYST BIOSCIENCES, INC. | Director | Series Y Preferred Stock | 0 | Aug 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GYRE | GYRE THERAPEUTICS, INC. | Jun 28, 2024 | 3 | -$17.5K | 4 | Jul 1, 2024 | Director |
GYRE | GYRE THERAPEUTICS, INC. | May 1, 2024 | 5 | -$144K | 4 | May 2, 2024 | Director |
GYRE | GYRE THERAPEUTICS, INC. | Apr 1, 2024 | 3 | -$184K | 4 | Apr 3, 2024 | Director |
GYRE | GYRE THERAPEUTICS, INC. | Mar 15, 2024 | 3 | -$207K | 4 | Mar 19, 2024 | Director |
CBIO | GYRE THERAPEUTICS, INC. | Oct 31, 2023 | 2 | $0 | 4 | Nov 1, 2023 | Director |
CBIO | CATALYST BIOSCIENCES, INC. | Aug 31, 2023 | 3 | $0 | 4 | Sep 1, 2023 | President & CEO, Director |
CBIO | CATALYST BIOSCIENCES, INC. | Aug 9, 2022 | 1 | $1.53K | 4 | Aug 10, 2022 | President & CEO, Director |
CBIO | CATALYST BIOSCIENCES, INC. | Feb 9, 2022 | 1 | $1.5K | 4 | Feb 16, 2022 | President & CEO, Director |
CBIO | CATALYST BIOSCIENCES, INC. | Aug 9, 2021 | 1 | $3.14K | 4 | Aug 11, 2021 | President & CEO, Director |